Target intelligence / Profile preview

Negatively charged phospholipid

Molecular classification
Other
01

Overview

Negatively charged phospholipids are a structural class of phospholipids in which the head group contains a net negative charge at physiological pH. The negative charge is typically due to the presence of a phosphate group (as in phosphatidic acid, phosphatidylglycerol, phosphatidylinositol) or additional charged side chains (as in phosphatidylserine). These molecules are major components of biological membranes, where they contribute to the asymmetry and selective permeability of the lipid bilayer[2][3][7]. The hydrophilic "head" contains the negatively charged phosphate moiety, while the hydrophobic "tails" comprise two fatty acids[4][7]. Negatively charged phospholipids interact with a variety of proteins, especially those involved in signaling, membrane fusion, and vesicle trafficking[5]. Importantly, their uneven distribution helps distinguish cell types and physiological states: for example, pathogens may have a much higher surface density of negatively charged phospholipids than host eukaryotic cells, and in mammalian cells, some (like phosphatidylserine) are sequestered on the inner leaflet except during apoptosis or cell stress[5]. Because of these selective distributions, several antimicrobial proteins and peptides exploit negatively charged phospholipids as a means of targeting pathogens, and externalized phosphatidylserine is a biomarker for apoptosis[5]. Phospholipids as a chemical class are not considered a therapeutic target (receptor, enzyme, transporter, etc.), but specific negatively charged phospholipid species (most notably phosphatidylserine) can play crucial roles in pathology and can be selectively recognized by engineered drugs, antibodies, or proteins[5].

Other names
Anionic phospholipidacidic phospholipid
02

Biological functions

Membrane structure and integritySelective permeability in cell membranesSignaling (including as a binding partner for proteins and peptides)Cell recognition
03

Disease associations

Infection (targeted by antimicrobial peptides/proteins)[5]Cancer (phosphatidylserine externalization in apoptosis can serve as a cancer biomarker and drug target)Other (membrane-related disorders, cell death/apoptosis)
04

Safety considerations

Off-target effects in therapies targeting cell membranesPotential disruption of host cell integrity and function if targeted indiscriminately
05

Biomarkers

Phosphatidylserine (exposed on the cell surface in apoptosis as a marker)[5]

Beyond the preview

Go deeper on Negatively charged phospholipid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Negatively charged phospholipid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call